Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
about
Red man syndromeVancomycin-induced hypertension with transient blindness and generalized seizureThe Mark Coventry Award: Higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trialBeta-lactam antibiotic sensitization and its relationship to allergic diseases in tertiary hospital nurses.Pediatric antibiotic therapy in 1990s.Vancomycin revisited - 60 years laterDesensitization protocols for vancomycin hypersensitivity.Vancomycin-associated spontaneous cutaneous adverse drug reactionsDifferential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation.Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.A clinical view of vancomycin in 1990.Ceftaroline in complicated skin and skin-structure infections.Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infectionAbsence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.Defining risk factors for red man syndrome in children and adults.Evaluation and management of pediatric drug allergic reactions.Immune-mediated reactions to vancomycin: A systematic case review and analysisVancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.An overlooked complication of vancomycin induced acute flaccid paralysis in a child with acute leukemia: a case report.A review of the Redman syndrome and rifampicin overdosage.Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusionsComparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers.Teicoplanin or vancomycin in the treatment of gram-positive infections?Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function.An unusual migratory polycyclic eruption after administration of prostaglandin E in a neonate.A closer look at vancomycin, teicoplanin, and antimicrobial resistance.Vancomycin-induced release of histamine from rat peritoneal mast cells and a rat basophil cell line (RBL-1).Vancomycin-induced red man syndrome in pediatric oncology: still an issue?A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated stud
P2860
Q21195101-3BC81B6F-851E-4B5F-AF21-A0F60892023EQ28319761-00466834-3A1F-4BA8-8CAC-51BC36AF091EQ30564105-832572EE-320E-4051-9764-25CBC5416E7FQ33758102-D01A1FE1-4BE0-4B0D-AC83-C70087F05B13Q33929008-D2138A66-074C-4052-A41A-55ABECE4FA16Q34433066-7A781DBD-B2F1-4C9E-AFF0-DE06B8CE34B9Q34449467-AFD9EEC8-AFD2-4813-BBAD-3A0F1754B06BQ35062240-BD662477-3C90-4245-A17B-B44298602810Q35091036-3DF388DA-B70C-4E48-A9A5-B56F60CD5807Q35123139-1E20EFD0-0597-44E0-8D36-53C294DFE822Q35643064-11AC6CA4-AF57-4920-ADCA-D0F8470C687EQ35715381-BAF838CC-1888-4EB5-99F6-F7973C38C645Q35821605-D0F279E4-D963-487A-A7C5-5F8747FD440BQ35862551-13E4F549-ADD0-414B-808A-24D472B3C713Q35906008-DDC87DDA-D0B0-47C2-9391-9B0BCCA57567Q36994645-4493DE73-A2F0-488B-A9E1-D59457452022Q37099007-5F319057-86C1-4BE1-851E-9BEFF5CCDCB8Q38258649-0272127A-4CEE-43B0-92D2-295BFAB8B5CCQ38683958-01A2E76E-75B8-4D9A-BAF0-B2257E3428F2Q38742596-5CFF8F61-04FB-447F-951B-B9776B84F309Q39815643-1E6EABDC-5A39-4CC6-87DD-907915244BB7Q39815862-863BFE32-0BD9-441E-A0F7-590EF19E492EQ39881946-D38023F6-F0C3-458D-A0C4-015B7C7FE490Q40541603-D61B03D6-F80F-415E-9E4A-42783B7ABB35Q40693689-E879707E-630B-4236-96BF-A6BCC9A9FB25Q41441580-C6947FBE-4A0E-46AE-936B-2CE482AF4C59Q41646436-A97DA3E9-7938-4D7A-98CF-6DC9DB02BAC3Q41693919-868DCD18-3421-4D8C-BF29-ED60BE60E2A2Q49039683-E5E3CAD3-FCFC-4252-A3D9-1250D6D06738Q55496455-561A6664-7677-4B9F-B04C-0CD4FC080421
P2860
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
description
1988 nî lūn-bûn
@nan
1988 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մարտին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@ast
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@en
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@nl
type
label
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@ast
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@en
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@nl
prefLabel
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@ast
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@en
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@nl
P2093
P3181
P356
P1476
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release
@en
P2093
P3181
P356
10.1093/INFDIS/157.3.502
P407
P577
1988-03-01T00:00:00Z